Gold Holds Above $4,600 as Treasury Buybacks Stir Debasement Bets
Commodities Rebecca Torres

Gold Holds Above $4,600 as Treasury Buybacks Stir Debasement Bets

Gold remains above $4,600 as Treasury buybacks fuel dollar-debasement trades. Spot gold rose 0.4%, gold ETFs saw inflows, and mining stocks outperformed.

GLD GDX CDE BTG
Take-Two Slides 2% as GTA VI Netflix Preview Kicks Off Final Marketing Push
Markets Daniel Marsh

Take-Two Slides 2% as GTA VI Netflix Preview Kicks Off Final Marketing Push

Take-Two (TTWO) shares dropped 2.1% as Rockstar's GTA VI Netflix preview begins the final marketing phase ahead of the November 19 launch. The company maintains its FY2027 bookings guidance of $8.0-$8.2 billion.

TTWO
10-Year Treasury Yield Hits 4.67% as Markets Await Fed's Jackson Hole Speech
Markets Daniel Marsh

10-Year Treasury Yield Hits 4.67% as Markets Await Fed's Jackson Hole Speech

The 10-year Treasury yield climbed to 4.67% on Thursday, buoyed by strong labor data, as investors positioned for Fed Chair Kevin Warsh's Jackson Hole speech on Friday.

TLT GLD USO
Salesforce Surge Lifts KASE Global as Asian Markets Close Mixed
Markets Daniel Marsh

Salesforce Surge Lifts KASE Global as Asian Markets Close Mixed

Salesforce's strong earnings and guidance lifted KASE Global shares, while Asian markets closed mixed. Korea and China advanced on AI hardware strength, but Japan and Hong Kong lagged.

CRM NVDA INTC BA UBER KO
Microsoft Prices Anniversary Xbox at $899.99 to Test Demand as Hardware Sales Slide
Technology Sarah Chen

Microsoft Prices Anniversary Xbox at $899.99 to Test Demand as Hardware Sales Slide

Microsoft's $899.99 Xbox Series X25 anniversary console hits preorders Thursday, a 12.5% premium over the standard model, as hardware revenue falls 29% in fiscal 2026.

MSFT SONY
Celularity Stock Surges 120% on MuseCell's $300M Manufacturing Deal
Markets Daniel Marsh

Celularity Stock Surges 120% on MuseCell's $300M Manufacturing Deal

Celularity shares more than doubled after MuseCell outlined a potential $300 million manufacturing relationship, though the estimate is non-binding and filings are overdue.

CELU
Synopsys Soars 10.7% as AI-Driven Demand Boosts Outlook
Earnings James Calloway

Synopsys Soars 10.7% as AI-Driven Demand Boosts Outlook

Synopsys shares surged 10.7% after reporting strong Q3 results and raising its full-year outlook, driven by AI-fueled chip design demand.

SNPS
Strategy Stock Soars 12% as Bitcoin Breaks $80K, Outpacing Crypto Fourfold
Crypto Sarah Chen

Strategy Stock Soars 12% as Bitcoin Breaks $80K, Outpacing Crypto Fourfold

Strategy shares jumped 12% to $137.95 as Bitcoin topped $80,000, with MSTR outpacing the crypto by 4x. Bitcoin holdings now worth $67.5 billion.

MSTR
Propanc Biopharma Rockets 151% on Promising PRP Pancreatic Cancer Data
Markets Daniel Marsh

Propanc Biopharma Rockets 151% on Promising PRP Pancreatic Cancer Data

Propanc Biopharma (PPCB) shares jumped 151% after PRP reduced tumor growth by over 90% in pancreatic cancer models, with volume nearly 20 times normal.

PPCB
Wendy's Shares Tumble 13% as Trian Abandons Take-Private Plans
Markets Daniel Marsh

Wendy's Shares Tumble 13% as Trian Abandons Take-Private Plans

Wendy's shares dropped 13% after top shareholder Trian Fund Management said it won't pursue a take-private deal, erasing the takeover premium.

WEN
Hormel Stock Plunges 9% on Retail Volume Drop, Sales Forecast Cut
Earnings James Calloway

Hormel Stock Plunges 9% on Retail Volume Drop, Sales Forecast Cut

Hormel (HRL) shares dropped 9% after retail volume fell 9% and the company cut its full-year sales outlook. Foodservice gains failed to offset the weakness.

HRL
Callaway Stock Slips as Retailers Pull Good Good Gear Amid Ad Controversy
Markets Daniel Marsh

Callaway Stock Slips as Retailers Pull Good Good Gear Amid Ad Controversy

Callaway shares dropped 1.3% as major retailers pulled Good Good products after a controversial driver ad. Despite the setback, Q2 golf equipment sales rose 4.5%.

CALY